Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?
Saved in:
| Title: | Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility? |
|---|---|
| Authors: | Petrelli F; Oncology Unit, ASST Bergamo Ovest, Treviglio (BG), Italy., Perego G; Pharmacy Unit, San Raffaele Hospital, Milano, Italy., Vavassori I; Urology Unit, ASST Bergamo Ovest, Treviglio (BG), Italy., Luciani A; Oncology Unit, ASST Bergamo Ovest, Treviglio (BG), Italy. |
| Source: | Tumori [Tumori] 2022 Oct; Vol. 108 (5), pp. 510-511. Date of Electronic Publication: 2021 Nov 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-2529 (Electronic) Linking ISSN: 03008916 NLM ISO Abbreviation: Tumori Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
